Cargando…

Clinical Characteristics and Outcomes of Hyphema in Patients with Sickle Cell Trait: 10-Year Experience at the Wilmer Eye Institute

PURPOSE: To report the clinical characteristics, complications, and outcomes of hyphema in patients with sickle cell trait (SCT). DESIGN: Retrospective case series. METHODS: Medical records of SCT patients (confirmed by hemoglobin electrophoresis) presenting with hyphema at the Wilmer Eye Institute...

Descripción completa

Detalles Bibliográficos
Autores principales: Mir, Tahreem, Iftikhar, Mustafa, Seidel, Natalie, Trang, Michelle, Goldberg, Morton F, Woreta, Fasika A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7719005/
https://www.ncbi.nlm.nih.gov/pubmed/33293789
http://dx.doi.org/10.2147/OPTH.S281875
_version_ 1783619604282605568
author Mir, Tahreem
Iftikhar, Mustafa
Seidel, Natalie
Trang, Michelle
Goldberg, Morton F
Woreta, Fasika A
author_facet Mir, Tahreem
Iftikhar, Mustafa
Seidel, Natalie
Trang, Michelle
Goldberg, Morton F
Woreta, Fasika A
author_sort Mir, Tahreem
collection PubMed
description PURPOSE: To report the clinical characteristics, complications, and outcomes of hyphema in patients with sickle cell trait (SCT). DESIGN: Retrospective case series. METHODS: Medical records of SCT patients (confirmed by hemoglobin electrophoresis) presenting with hyphema at the Wilmer Eye Institute over 10 years (January 2008 through December 2017) were reviewed in detail. Data were collected regarding etiology, demographics, clinical course and management. Main outcome measures included intraocular pressure (IOP) and visual acuity (VA). RESULTS: A total of 14 black patients (males: 57%; median age: 20 years) were included in the study with a median follow-up of 4 months (range: 1 week to 6 years). Ten patients had traumatic hyphema with a mean presenting VA of approximately 1.10 logMAR (Snellen equivalent=20/250) and a mean presenting IOP of 40 mmHg. Nine of them required medical intervention to lower IOP, and six of them ultimately required surgical intervention, primarily in the form of anterior chamber paracentesis and/or washout. The mean time to achieve IOP control was 3 days, and the mean final VA was approximately 0.10 logMAR (Snellen Equivalent=20/25). Four patients had non-traumatic hyphema with a mean presenting VA of approximately 1.8 logMAR (Snellen equivalent=20/1260) and a mean presenting IOP of 31 mmHg. Three of them required medical intervention to lower IOP, and two of them ultimately required surgical intervention. Overall, seven patients underwent anterior chamber washout, six needed an anterior chamber paracentesis to lower the IOP, two required tube shunt placement procedures and one patient underwent a trabeculectomy. The mean time to achieve IOP control was 5 days, and the mean final VA was approximately 0.80 logMAR (Snellen equivalent=20/125). CONCLUSION: Patients with SCT are likely to develop elevated IOP in the setting of hyphema, with a majority requiring one or more surgical interventions to achieve IOP control.
format Online
Article
Text
id pubmed-7719005
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-77190052020-12-07 Clinical Characteristics and Outcomes of Hyphema in Patients with Sickle Cell Trait: 10-Year Experience at the Wilmer Eye Institute Mir, Tahreem Iftikhar, Mustafa Seidel, Natalie Trang, Michelle Goldberg, Morton F Woreta, Fasika A Clin Ophthalmol Original Research PURPOSE: To report the clinical characteristics, complications, and outcomes of hyphema in patients with sickle cell trait (SCT). DESIGN: Retrospective case series. METHODS: Medical records of SCT patients (confirmed by hemoglobin electrophoresis) presenting with hyphema at the Wilmer Eye Institute over 10 years (January 2008 through December 2017) were reviewed in detail. Data were collected regarding etiology, demographics, clinical course and management. Main outcome measures included intraocular pressure (IOP) and visual acuity (VA). RESULTS: A total of 14 black patients (males: 57%; median age: 20 years) were included in the study with a median follow-up of 4 months (range: 1 week to 6 years). Ten patients had traumatic hyphema with a mean presenting VA of approximately 1.10 logMAR (Snellen equivalent=20/250) and a mean presenting IOP of 40 mmHg. Nine of them required medical intervention to lower IOP, and six of them ultimately required surgical intervention, primarily in the form of anterior chamber paracentesis and/or washout. The mean time to achieve IOP control was 3 days, and the mean final VA was approximately 0.10 logMAR (Snellen Equivalent=20/25). Four patients had non-traumatic hyphema with a mean presenting VA of approximately 1.8 logMAR (Snellen equivalent=20/1260) and a mean presenting IOP of 31 mmHg. Three of them required medical intervention to lower IOP, and two of them ultimately required surgical intervention. Overall, seven patients underwent anterior chamber washout, six needed an anterior chamber paracentesis to lower the IOP, two required tube shunt placement procedures and one patient underwent a trabeculectomy. The mean time to achieve IOP control was 5 days, and the mean final VA was approximately 0.80 logMAR (Snellen equivalent=20/125). CONCLUSION: Patients with SCT are likely to develop elevated IOP in the setting of hyphema, with a majority requiring one or more surgical interventions to achieve IOP control. Dove 2020-12-01 /pmc/articles/PMC7719005/ /pubmed/33293789 http://dx.doi.org/10.2147/OPTH.S281875 Text en © 2020 Mir et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Mir, Tahreem
Iftikhar, Mustafa
Seidel, Natalie
Trang, Michelle
Goldberg, Morton F
Woreta, Fasika A
Clinical Characteristics and Outcomes of Hyphema in Patients with Sickle Cell Trait: 10-Year Experience at the Wilmer Eye Institute
title Clinical Characteristics and Outcomes of Hyphema in Patients with Sickle Cell Trait: 10-Year Experience at the Wilmer Eye Institute
title_full Clinical Characteristics and Outcomes of Hyphema in Patients with Sickle Cell Trait: 10-Year Experience at the Wilmer Eye Institute
title_fullStr Clinical Characteristics and Outcomes of Hyphema in Patients with Sickle Cell Trait: 10-Year Experience at the Wilmer Eye Institute
title_full_unstemmed Clinical Characteristics and Outcomes of Hyphema in Patients with Sickle Cell Trait: 10-Year Experience at the Wilmer Eye Institute
title_short Clinical Characteristics and Outcomes of Hyphema in Patients with Sickle Cell Trait: 10-Year Experience at the Wilmer Eye Institute
title_sort clinical characteristics and outcomes of hyphema in patients with sickle cell trait: 10-year experience at the wilmer eye institute
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7719005/
https://www.ncbi.nlm.nih.gov/pubmed/33293789
http://dx.doi.org/10.2147/OPTH.S281875
work_keys_str_mv AT mirtahreem clinicalcharacteristicsandoutcomesofhyphemainpatientswithsicklecelltrait10yearexperienceatthewilmereyeinstitute
AT iftikharmustafa clinicalcharacteristicsandoutcomesofhyphemainpatientswithsicklecelltrait10yearexperienceatthewilmereyeinstitute
AT seidelnatalie clinicalcharacteristicsandoutcomesofhyphemainpatientswithsicklecelltrait10yearexperienceatthewilmereyeinstitute
AT trangmichelle clinicalcharacteristicsandoutcomesofhyphemainpatientswithsicklecelltrait10yearexperienceatthewilmereyeinstitute
AT goldbergmortonf clinicalcharacteristicsandoutcomesofhyphemainpatientswithsicklecelltrait10yearexperienceatthewilmereyeinstitute
AT woretafasikaa clinicalcharacteristicsandoutcomesofhyphemainpatientswithsicklecelltrait10yearexperienceatthewilmereyeinstitute